Services & Expertises
Built For Your Needs
InVivoPath offers elite fractional preclinical leadership for emerging biotech ventures.
We provide high-level scientific direction and bespoke research roadmaps optimized for your therapeutic goals, bypassing the heavy costs of a permanent executive.
What we do
01 — Preclinical Strategy & Program Leadership
InVivoPath serves as your embedded head of preclinical development, providing high-level oversight from model selection through the design of IND-enabling studies.
We specialize in developing technical roadmaps aligned with your regulatory milestones, validating specific disease models—including MASH/MASLD, fibrosis, IPF, obesity, and neurodegeneration—and interpreting complex datasets to provide the critical go/no-go insights necessary to advance your therapeutic pipeline.
Engagement model: ongoing advisory retainer
(monthly or milestone-based).
Engagement model: project-based or ongoing, depending on study complexity.
02 — CRO Management & Liaison
InVivoPath supports CRO selection and RFP evaluation, serves as the scientific point of contact between your team and the execution team running your studies, and provides ongoing quality and timeline oversight across concurrent programs.
Built on direct, hands-on experience managing the CRO side of 50+ client preclinical programs annually for a decade, InVivoPath knows, from firsthand operational experience, where study timelines slip and where data quality issues originate.This is a relationship-management and oversight service — InVivoPath does not itself execute studies.
03 — Preclinical Data Standardization & Analytics
Preclinical programs generate data across multiple studies, formats, and vendors — data that is only as useful as it is comparable.
InVivoPath builds custom data standardization pipelines to clean, structure, and harmonize preclinical endpoints across studies, for applying machine learning approaches to surface patterns manual review alone would miss.
Engagement model: project-based, scoped to your dataset and study portfolio.
04 — Scientific Due Diligence & Investment Support
InVivoPath provides scientific due diligence for investors, family offices, and business development teams evaluating biotech opportunities in metabolic, fibrotic, and neurodegenerative disease. This assesses scientific validity and translational risk, including competitive landscape analysis and non-technical summaries for confident decision-making.